Pfizer joins open-access medicinal chemistry public-private collaboration | EurekAlert! Science News

"The Structural Genomics Consortium (SGC) and Pfizer today announced that Pfizer will join the SGC-led public-private collaboration to generate small molecule inhibitors – 'chemical probes' – for proteins involved in epigenetic signalling. Pfizer and GlaxoSmithKline (GSK) are now members of this collaboration, launched in late 2008 with the aim to provide the community with high quality research reagents, free from restriction on use...."